RE: Poolbeg Sunday Times20 Jun 2021 14:02
I think today’s coverage will silence the critics. It goes to show that as its own entity, with its own board and its own vision, a spin out pharma has the potential to do way more, and way better, than it ever would as part of open orphan. I remember the day that we had the big drop on the first spin out RNS and some people scoffing at this just because it wasn’t DIM. Yet already this feels really exciting and I plan to buy a few shares at IPO.
I really like the sound of Jeremy Skillington, he’s got quite the CV. From the website, the vision is clear:
“Poolbeg is led by a team with proven capabilities in identifying, acquiring and accelerating assets through development to commercialisation.”
This isn’t a POLB001 one trick pony, they plan to acquire (which CF is a specialist at)and/or develop a range of promising treatments. I wouldn’t be surprised if they already have their eye on a few treatments that the IPO money could allow them to buy and develop. Could be huge.